Targeting "Natural Born Killers" to Modulate Immune Suppression in Neurocritical Care

Affiliations

¹ Department of Critical Care Medicine, Safar Center for Resuscitation Research, School of Medicine, University of Pittsburgh, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, John G. Rangos Research Center, 6th Floor 4401 Penn Avenue, Pittsburgh, PA, USA.
² Division of Rheumatology and Clinical Immunology, Department of Medicine, School of Medicine, University of Pittsburgh, BST South, S719 3500 Terrace Street, Pittsburgh, PA, USA.
³ Department of Critical Care Medicine, Safar Center for Resuscitation Research, School of Medicine, University of Pittsburgh, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, John G. Rangos Research Center, 6th Floor 4401 Penn Avenue, Pittsburgh, PA, USA. kochanekpm@pitt.edu.

Comment

Dennis W Simon et al. Neurocrit Care. 2021 Dec.

. 2021 Dec;35(3):608-610.

doi: 10.1007/s12028-021-01235-y. Epub 2021 Jun 1.

¹ Department of Critical Care Medicine, Safar Center for Resuscitation Research, School of Medicine, University of Pittsburgh, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, John G. Rangos Research Center, 6th Floor 4401 Penn Avenue, Pittsburgh, PA, USA.
² Division of Rheumatology and Clinical Immunology, Department of Medicine, School of Medicine, University of Pittsburgh, BST South, S719 3500 Terrace Street, Pittsburgh, PA, USA.
³ Department of Critical Care Medicine, Safar Center for Resuscitation Research, School of Medicine, University of Pittsburgh, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, John G. Rangos Research Center, 6th Floor 4401 Penn Avenue, Pittsburgh, PA, USA. kochanekpm@pitt.edu.

No abstract available

Comment on

Exploratory Evaluation of the Relationship Between iNKT Cells and Systemic Cytokine Profiles of Critically Ill Patients with Neurological Injury.
Scott BNV, Kramer AH, Nguyen R, Wong CHY, Jenne CN, Ruddell S, Wong J, Tse M, Winston BW, Soo A, Doig CJ, Zygun DA, Kubes P. Scott BNV, et al. Neurocrit Care. 2021 Dec;35(3):617-630. doi: 10.1007/s12028-021-01234-z. Epub 2021 Jun 1. Neurocrit Care. 2021. PMID: 34061312

1. Kourbeti IS, Vakis AF, Papadakis JA, Karabetsos DA, Bertsias G, Filippou M, et al. Infections in traumatic brain injury patients. Clin Microbiol Infect. 2012;18(4):359–64. - DOI
1. Simon DW, McGeachy MJ, Bayır H, Clark RSB, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol. 2017;13(3):171–191. Erratum in: Nat Rev Neurol. 2017;13(9):572.
1. Vermeij FH, Op Reimer WJMS, de Man P, van Oostenbrugge RJ, Franke CL, de Jong G, et al. Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis. 2009;27(5):465–71. - DOI
1. Westendorp WF, Nederkoorn PJ, Vermeij J-D, Dijkgraaf MG, van de Beek D. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 2011;11:110. - DOI
1. Kesinger MR, Kumar RG, Wagner AK, Puyana JC, Peitzman AP, Billiar TR, et al. Hospital-acquired pneumonia is an independent predictor of poor global outcome in severe traumatic brain injury up to 5 years after discharge. J Trauma Acute Care Surg. 2015;78(2):396–402. - DOI